US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

266.00

-13.0200-4.67%

Post-market: 264.12-1.8800-0.71%19:53 EDT

Volume:290.13K

Turnover:77.49M

Market Cap:498.61M

PE:- -

High:274.71

Open:269.37

Low:260.01

Close:279.02

52wk High:341.93

52wk Low:74.95

Shares:1.87M

Float Shares:1.87M

Volume Ratio:0.94

T/O Rate:15.48%

Dividend:1.00

Dividend Rate:0.38%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Ramsay Health Care (RMSYF) Gets a Sell from Morgan Stanley

IHH Healthcare Unlikely to be Impacted by Fortis Legal Proceedings

Sigma Healthcare updates CEO equity holdings under incentive plan

Regis Director Hodges Increases Indirect Shareholding via On-Market Purchase

Bubs Australia Wins Permanent FDA Approval to Supply U.S. Infant Formula Market

Regis Healthcare Faces Margin Pressure From Inadequate Aged-Care Funding, Jefferies Says

MT Newswires Live

Director Buying in Stamford Land, Foundation Healthcare, Lincotrade and ISOTeam

Gen Ilac Expands Healthcare Footprint Through Network of Subsidiaries and Strategic Investments

Wall Street Analysts Are Bullish on Top Healthcare Picks

Spire Healthcare overhauls board amid £1bn private takeover

The GLP-1 Squeeze: How Soaring Healthcare Costs are Forcing Employers to Act

Anlon Healthcare Reports Virtual 13th AGM Proceedings to Exchanges

AstraZeneca's New Breast Cancer Therapy Secures FDA Green Light, Analysts Project $2.3 Billion in Sales by 2032

Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Guardant announces FDA approval of Guardant360 CDx as companion diagnostic

AstraZeneca Gets FDA Approval for Breast Cancer Treatment

Health Care Down on Retreat from Risky Biotech Area - Health Care Roundup

Ionis Pharmaceuticals: Buy Rating Backed by FDA Approval of Zanvastro and Strengthened Neurology Pipeline Upside

Aster DM Quality Care Calls Remote AGM, Releases FY 2025-26 Integrated Report

Healthcare Stocks Pick up Steam as Investors Play Offense and Defense

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/LABU/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":266,"timestamp":1789070400000,"preClose":279.02,"halted":0,"volume":290130,"hourTrading":{"tag":"盘后","latestPrice":264.12,"preClose":266,"latestTime":"19:53 EDT","volume":1904,"amount":504475.6573,"timestamp":1789084425326,"change":-1.88,"changeRate":-0.007068,"amplitude":0.00782},"delay":0,"changeRate":-0.046663321625689855,"floatShares":1874486,"shares":1874486,"eps":0,"marketStatus":"Closed","change":-13.02,"latestTime":"09-10 16:00:00 EDT","open":269.37,"high":274.705,"low":260.01,"amount":77488111.8858,"amplitude":0.052666,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789113600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":279.02,"sharesOutstanding":3074486,"nav":278.651,"aum":522328218.83,"dividendRate":0.003776,"bidAskSpread":0.002964,"preHourTrading":{"tag":"盘前","latestPrice":268.99,"preClose":279.02,"latestTime":"09:29 EDT","volume":1828,"amount":503835.0052,"timestamp":1789046962415,"change":-10.03,"changeRate":-0.035947,"amplitude":0.054249},"postHourTrading":{"tag":"盘后","latestPrice":264.12,"preClose":266,"latestTime":"19:53 EDT","volume":1904,"amount":504475.6573,"timestamp":1789084425326,"change":-1.88,"changeRate":-0.007068,"amplitude":0.00782},"volumeRatio":0.944317,"impliedVol":0.9105,"impliedVolPercentile":0.502},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1874486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.944317,"shares":1874486,"dividePrice":1.0045,"high":274.705,"amplitude":0.052666,"preClose":279.02,"low":260.01,"week52Low":74.95,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":266,"eps":0,"divideRate":0.003776,"volume":290130,"delay":0,"ttmEps":0,"open":269.37,"prevYearClose":159.39,"prevWeekClose":303.55,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":311.81,"twentyDayClose":286.75,"sixtyDayClose":188.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665393695","title":"Ramsay Health Care (RMSYF) Gets a Sell from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2665393695","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665393695?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:35","pubTimestamp":1788744914,"startTime":"0","endTime":"0","summary":"In a report released on September 3, David Bailey from Morgan Stanley maintained a Sell rating on Ramsay Health Care, with a price target of A$41.9...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-sell-from-morgan-stanley-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-sell-from-morgan-stanley-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","BK4581","RMSYF","BK4588","XLV","BK4585","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665393855","title":"IHH Healthcare Unlikely to be Impacted by Fortis Legal Proceedings","url":"https://stock-news.laohu8.com/highlight/detail?id=2665393855","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665393855?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:18","pubTimestamp":1788743880,"startTime":"0","endTime":"0","summary":"0118 GMT - The legal proceedings between Fortis and Daiichi Sankyo aren't expected to have material impact on IHH's associate Fortis's operations, CIMB Securities analyst Chun Sung Oong says in a note. IHH's 31.1% stake in Fortis was acquired through a fresh 40 billion rupee capital injection, with no money paid directly to the former Fortis promoters, the Singh brothers. The acquisition is therefore seen as having been conducted at arm's length, with no evidence of direct dealings with the former promoters, he says. IHH also reaffirmed its intention to gradually raise its stake in Fortis to 51% over the next four years, which is expected to have minimal impact on its target price. CIMB maintains a buy rating on IHH and its target price at 10.30 ringgit. Shares are at 7.96 ringgit.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6511","LU0128526141.USD","LABU","BK4585","HCSG","BK4581","XLV","BK4588","BK6092","LU0029874061.USD","BK4137","Q0F.SI","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398069","title":"Sigma Healthcare updates CEO equity holdings under incentive plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398069?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:13","pubTimestamp":1788743609,"startTime":"0","endTime":"0","summary":"The latest update is out from Sigma Healthcare Ltd ( ($AU:SIG) ). Sigma Healthcare has disclosed a change in the interests of Managing Director and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-updates-ceo-equity-holdings-under-incentive-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sigma-healthcare-updates-ceo-equity-holdings-under-incentive-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","LU0128526141.USD","BK4588","HCSG","BK4585","BK4137","BK4581","LU0029874061.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665601563","title":"Regis Director Hodges Increases Indirect Shareholding via On-Market Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2665601563","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665601563?lang=en_us&edition=fundamental","pubTime":"2026-09-07 07:47","pubTimestamp":1788738470,"startTime":"0","endTime":"0","summary":"The latest update is out from Regis Healthcare Ltd. ( ($AU:REG) ). Regis Healthcare Ltd has disclosed a change in director Graham Kennedy Hodges’ i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regis-director-hodges-increases-indirect-shareholding-via-on-market-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regis-director-hodges-increases-indirect-shareholding-via-on-market-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4581","XLV","BK4588","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665360188","title":"Bubs Australia Wins Permanent FDA Approval to Supply U.S. Infant Formula Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2665360188","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665360188?lang=en_us&edition=fundamental","pubTime":"2026-09-07 07:25","pubTimestamp":1788737127,"startTime":"0","endTime":"0","summary":"Bubs Australia Ltd. ( ($AU:BUB) ) has provided an announcement. Bubs Australia has secured permanent regulatory authorisation from the U.S. Food an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bubs-australia-wins-permanent-fda-approval-to-supply-u-s-infant-formula-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bubs-australia-wins-permanent-fda-approval-to-supply-u-s-infant-formula-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665339360","title":"Regis Healthcare Faces Margin Pressure From Inadequate Aged-Care Funding, Jefferies Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2665339360","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665339360?lang=en_us&edition=fundamental","pubTime":"2026-09-07 07:21","pubTimestamp":1788736888,"startTime":"0","endTime":"0","summary":"Regis Healthcare (ASX:REG) faces weaker fiscal 2027 earnings growth as the 2.6% increase in Australian National Aged Care Classification (AN-ACC) funding to AU$303.19 per resident per day falls short ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0029874061.USD","BK7113","BK4588","REG.AU","BK4585","XLV","BK4137","LU0128526141.USD","XBI","HCSG","BK4581","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665034803","title":"Director Buying in Stamford Land, Foundation Healthcare, Lincotrade and ISOTeam","url":"https://stock-news.laohu8.com/highlight/detail?id=2665034803","media":"sgx.com","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665034803?lang=en_us&edition=fundamental","pubTime":"2026-09-07 00:00","pubTimestamp":1788710400,"startTime":"0","endTime":"0","summary":"Over the five sessions, 100 director interests and substantial shareholdings were filed for more than 40 primary-listed stocks.Directors or CEOs reported 25 acquisitions and six disposals, while subst","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sgx_market_highlight","url":"https://www.sgx.com/research-education/market-updates/20260907-director-buying-stamford-land-foundation-healthcare","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.sgx.com/research-education/market-updates/20260907-director-buying-stamford-land-foundation-healthcare","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sgx_market_highlight","symbols":["SRU.SI","GLS.SI","CLR.SI","SRT.SI","BK4588","5WF.SI","BK6520","BK4137","BK6014","LU0128526141.USD","CFA.SI","BFT.SI","BK6100","XBI","BK6045","XLV","FHH.SI","AJBU.SI","BK6512","BK6131","JJJ.SI","LABU","LU0029874061.USD","BK6019","BK4585","BK4581","HCSG","BK6501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665605362","title":"Gen Ilac Expands Healthcare Footprint Through Network of Subsidiaries and Strategic Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2665605362","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665605362?lang=en_us&edition=fundamental","pubTime":"2026-09-06 22:42","pubTimestamp":1788705746,"startTime":"0","endTime":"0","summary":"Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. ( ($TR:GENIL) ) has issued an announcement. Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gen-ilac-expands-healthcare-footprint-through-network-of-subsidiaries-and-strategic-investments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gen-ilac-expands-healthcare-footprint-through-network-of-subsidiaries-and-strategic-investments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XBI","LU0029874061.USD","BK4585","BK4137","HCSG","LU0128526141.USD","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665136106","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2665136106","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665136106?lang=en_us&edition=fundamental","pubTime":"2026-09-06 17:00","pubTimestamp":1788685240,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Akeso, Inc. (HK:9926) and Sino Biopharmaceutical (SB...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-329?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-329?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4581","XBI","BK4588","LABU","LU0029874061.USD","HCSG","XLV","BK4137","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665361714","title":"Spire Healthcare overhauls board amid £1bn private takeover","url":"https://stock-news.laohu8.com/highlight/detail?id=2665361714","media":"cityam","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665361714?lang=en_us&edition=fundamental","pubTime":"2026-09-06 16:49","pubTimestamp":1788684585,"startTime":"0","endTime":"0","summary":"Spire Healthcare becomes the latest listed firm to quit the public market The chief executive and chair of Spire Healthcare have stepped away amid a 1bn takeover of the London-listed private hospital group.Veteran boss Justin Ash has said he will retire from the group as it “enters a new phase with strong foundations” under its new ownership by a consortium of investors.Spire’s board have agreed a takeover by Tulip UK Bidco, a new company comprising British investment firm Toscafund, UK private equity firm THCP Advisory and California-based investment manager Ares.White stepped down as chair of Co-op with immediate effect last month, following a tenure mired by a disastrous cyberattack and disputed claims of a “toxic” work culture.‘Share price volatility’Announcing their takeover of Spire, the consortium said the value of the healthcare group’s freehold property assets is not reflected in its share price.“The Bidco board believes that taking the Spire Group private pursuant to the acqu","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2025/12/London-Stock-Exchange-1.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2025/12/London-Stock-Exchange-1.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/spire-healthcare-overhauls-board-amid-1bn-private-takeover/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/spire-healthcare-overhauls-board-amid-1bn-private-takeover/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["LU0029874061.USD","HCSG","LU0128526141.USD","BK4581","LABU","BK4588","BK4137","BK4585","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665361557","title":"The GLP-1 Squeeze: How Soaring Healthcare Costs are Forcing Employers to Act","url":"https://stock-news.laohu8.com/highlight/detail?id=2665361557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665361557?lang=en_us&edition=fundamental","pubTime":"2026-09-06 15:00","pubTimestamp":1788678000,"startTime":"0","endTime":"0","summary":"As employers brace for a fresh round of rising healthcare costs that outpace inflation, the stakes are getting higher for companies to contain spending on treatments such as popular GLP-1 medications ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XLV","BK4588","BK4581","XBI","LABU","EIG","BK4107","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665368256","title":"Anlon Healthcare Reports Virtual 13th AGM Proceedings to Exchanges","url":"https://stock-news.laohu8.com/highlight/detail?id=2665368256","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665368256?lang=en_us&edition=fundamental","pubTime":"2026-09-05 17:03","pubTimestamp":1788598999,"startTime":"0","endTime":"0","summary":"Anlon Healthcare Limited ( ($IN:AHCL) ) just unveiled an update. Anlon Healthcare Limited held its 13th Annual General Meeting on September 5, 2025...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anlon-healthcare-reports-virtual-13th-agm-proceedings-to-exchanges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anlon-healthcare-reports-virtual-13th-agm-proceedings-to-exchanges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","XBI","XLV","LABU","LU0128526141.USD","BK4137","BK4585","BK4581","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114881234","title":"AstraZeneca's New Breast Cancer Therapy Secures FDA Green Light, Analysts Project $2.3 Billion in Sales by 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=1114881234","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114881234?lang=en_us&edition=fundamental","pubTime":"2026-09-05 13:56","pubTimestamp":1788587772,"startTime":"0","endTime":"0","summary":"AstraZeneca's oral breast cancer medication has received approval from the US Food and Drug Administration. This decision marks a significant win for the pharmaceutical giant, particularly after the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4585","FAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665613352","title":"Schedule update: Stryker to participate in the 2026 Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2665613352","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665613352?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:32","pubTimestamp":1788561120,"startTime":"0","endTime":"0","summary":"Portage, Michigan, Sept.  04, 2026  -- Stryker  will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor, as previously reported. Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will now participate in a fireside chat session at 10:15 a.m. . A simultaneous live audio webcast and replay of the session can be accessed atStryker - Events & Presentations. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com. Contacts For investor inquiries:Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/04/3356840/0/en/schedule-update-stryker-to-participate-in-the-2026-wells-fargo-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTXO","LU1983299246.USD","KBWB","LU2236285917.USD","LU0640476718.USD","LU0868494708.USD","IYF","LU0477156953.USD","LU0251142724.SGD","LU1035773651.USD","PGF","XBI","LU0128526141.USD","LU0149725797.USD","LU2404859741.USD","BK4137","BK4581","LU0432979614.USD","BK4585","LU0683600562.USD","LU0130517989.USD","LU0162691827.USD","LU0882574055.USD","LU1069347547.HKD","LU1363072403.SGD","LU0417517546.SGD","LU0314106906.USD","IE00B19Z3581.USD","LU0029864427.USD","LU2361044865.SGD","LU1894683348.USD","TFNS","LU0251131958.USD","IHI","LU2361045086.USD","GB00B4LPDJ14.GBP","XLV","HCSG","LABU","LU0048573561.USD","LU0648001328.SGD","SYK","LU0950375773.USD","LU0823417653.USD","LU1506573853.SGD","LU1791710400.SGD","LU0128525929.USD","GB00B4QBRK32.GBP","LU2461242641.AUD","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354019","title":"Guardant announces FDA approval of Guardant360 CDx as companion diagnostic","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354019","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354019?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:15","pubTimestamp":1788560112,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced that the U.S. Food and Drug Administration has approved Guardant360 CDx as a companion diagnostic to identify patien...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-announces-fda-approval-of-guardant360-cdx-as-companion-diagnostic-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","GNMX","LABU","GDOC","IEIH","IYH","PINK","EKG","TECB","FRTY","LU0320765992.SGD","IDNA","LFSC","RSPH","NVIB","LU0109394709.USD","GNOM","BK4551","MEDI","BK4196","HELX","LU0889565916.HKD","XLVX","BMED","PTH","BK4585","GH","TBXU","BBP","PSCH","BK4535","IBB","FFOX","SYNB","MRNY","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354734","title":"AstraZeneca Gets FDA Approval for Breast Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354734","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354734?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:07","pubTimestamp":1788559620,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration approved an AstraZeneca-made treatment for advanced breast cancer.The agency on Friday said it granted accelerated approval for AstraZeneca's Etcamah drug, known generically as camizestrant, in combination with a CDK4/6 inhibitor to treat eligible breast cancer patients.The approval applies to adults with HR-positive, HER2-negative locally advanced or metastatic breast cancer, after detection of an estrogen receptor-1 mutation during aromatase inhibitor and CDK 4/6 inhibitor therapy.The FDA also approved a companion diagnostic test to detect emerging ESR1 resistance mutations, the company said.\"The Etcamah combination reflects AstraZeneca's leadership in redefining breast cancer care by pioneering a new approach using circulating tumour DNA and is the first and only medicine of its type in the 1st-line setting,\" AstraZeneca's executive vice president of the oncology haematology business unit, Dave Fredrickson said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930573.SGD","LU0432979614.USD","LU0708994859.HKD","BK4568","LABU","LU2237443978.SGD","AZN","LU0889565916.HKD","LU2089984988.USD","BK4585","LU2237443549.SGD","BK4588","LU2417539215.USD","LU0289739699.SGD","LU1829250122.USD","LU2237443465.HKD","LU2237443382.USD","LU0029864427.USD","LU0109394709.USD","LU0058720904.USD","LU0320765992.SGD","LU2237443622.USD","LU2237443895.HKD","LU0128525929.USD","AZNH","LU2456880835.USD","BK4007","LU2236285917.USD","LU2462157665.USD","LU0310800379.SGD","LU2468319806.SGD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665354869","title":"Health Care Down on Retreat from Risky Biotech Area - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2665354869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665354869?lang=en_us&edition=fundamental","pubTime":"2026-09-05 05:10","pubTimestamp":1788556200,"startTime":"0","endTime":"0","summary":"Health-care companies fell as traders retreated from high-risk corners of the market such as biotechnology and obesity-drug makers.The iShares Biotech exchange-traded fund, a basket of major biotech firms, slipped by 0.9%, but remains near all-time highs. Merger activity and breakthroughs in oncology have reinvigorated investor enthusiasm for the sub sector in recent weeks.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","BK4588","LABU","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351966","title":"Ionis Pharmaceuticals: Buy Rating Backed by FDA Approval of Zanvastro and Strengthened Neurology Pipeline Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351966","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351966?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:35","pubTimestamp":1788554117,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has reiterated their bullish stance on IONS stock, giving a Buy rating today. Myles Minter has given his Buy rat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ionis-pharmaceuticals-buy-rating-backed-by-fda-approval-of-zanvastro-and-strengthened-neurology-pipeline-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ionis-pharmaceuticals-buy-rating-backed-by-fda-approval-of-zanvastro-and-strengthened-neurology-pipeline-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IONS","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665516443","title":"Aster DM Quality Care Calls Remote AGM, Releases FY 2025-26 Integrated Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2665516443","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665516443?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:33","pubTimestamp":1788553994,"startTime":"0","endTime":"0","summary":"Aster DM Healthcare Ltd. ( ($IN:ASTERDM) ) has shared an announcement. Aster DM Quality Care Limited has released its Integrated Annual Report for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-calls-remote-agm-releases-fy-2025-26-integrated-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aster-dm-quality-care-calls-remote-agm-releases-fy-2025-26-integrated-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4581","BK4588","XBI","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665351836","title":"Healthcare Stocks Pick up Steam as Investors Play Offense and Defense","url":"https://stock-news.laohu8.com/highlight/detail?id=2665351836","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665351836?lang=en_us&edition=fundamental","pubTime":"2026-09-05 04:22","pubTimestamp":1788553320,"startTime":"0","endTime":"0","summary":"Want a prescription for investing success?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","LU0198837287.USD","LU1804176565.USD","MRNA","LU1323610961.USD","LU0289739699.SGD","SG9999013999.USD","LU0316494557.USD","LU0096364046.USD","LU2756315318.SGD","BK4501","IE00BJJMRY28.SGD","LU2023250330.USD","LU0109394709.USD","LU0158827948.USD","LU0210536198.USD","IE00BJT1NW94.SGD","LU0320765059.SGD","TRUH","LU2264538146.SGD","LLY","BK4007","LU2211815571.USD","LU1069344957.HKD","LU1868837136.USD","LU0256863902.USD","LU2087625088.SGD","LU2237443978.SGD","LU2552382215.SGD","BK4532","LU0058720904.USD","LU0345770308.USD","IHF","LLYX","LU0708995401.HKD","LU1551013425.SGD","LU2324357040.USD","LU2746668461.USD","LU0354030511.USD","LU2168564065.EUR","JDOC","LU0320765992.SGD","MEDI","IE00BFSS8Q28.SGD","LLII","LU0225283273.USD","LU2552382058.USD","MRNY","BK4533","LU0114720955.EUR","LU2168564222.USD","LU2746668974.SGD","WDNA","LU2265009873.SGD","LU0882574139.USD","LU2028103732.USD","SG9999014880.SGD","LU2089984988.USD","SG9999014898.SGD","SGXZ31699556.SGD","LU1868836914.USD","SGXZ99366536.SGD","IE00BFTCPJ56.SGD","LU2089284900.SGD","LGHT","IE00B775H168.HKD","LU1057294990.SGD","LU2471134879.HKD","SG9999015945.SGD","LU1720051108.HKD","LU0097036916.USD","SG9999001176.USD","LU1814569148.SGD","LU2106854487.HKD","BK4568","LU2360106947.USD","LU0158827781.USD","IDNA","ELIL","IE0005OL40V9.USD","LU0345770993.USD","LU0266013472.USD","OZEM","RXL","XBI","LU2896262040.SGD","BK4581","LU1232071149.USD","LU2089283258.USD","LU2468319806.SGD","LU2462157665.USD","LU0786609619.USD","LU0094547139.USD","LU1868837300.USD","LU2063271972.USD","LU0061475181.USD","LU0683600562.USD","LU0133085943.USD","ILDR","SG9999017495.SGD","IE00B1XK9C88.USD","LU0471298777.SGD","LU1267930730.SGD","LU0964807845.USD","LU2111349929.HKD","LU2237443622.USD","LU0385154629.USD","AGNG","IE00B7KXQ091.USD","LU2237438978.USD","LU2491049909.HKD","LU2168564495.EUR","LU2552382132.HKD","LU1093756168.USD","LU0471298694.HKD","LU1551013342.USD","LU1127390331.HKD","LU0456855351.SGD","SG9999001176.SGD","ELIS","LU2023250504.SGD","LU0174119429.USD","LU1979441026.SGD","LU2271345857.HKD","MHIP","LU0787776722.HKD","IE00BJJMRZ35.SGD","LU2237443382.USD","LU2456880835.USD","LU1548497426.USD","LU0417517546.SGD","TMED","IE00BJLML261.HKD","LU2491050154.USD","LU0203201768.USD","IE00BN29S564.USD","LU0889565916.HKD","LU1064131342.USD","LU2471134523.USD","FHLC","IE0004445015.USD","LU2491050071.SGD","LU2236285917.USD","LU2756315664.SGD","LU0823434583.USD","MEDX","LU0820561909.HKD","LU1291159041.SGD","SGXZ57979304.SGD","IHE","LU1280957306.USD","LU2750360997.AUD","LU0106261372.USD","IE00B1BXHZ80.USD","LU1712237335.SGD","LU1145028129.USD","LU0823434740.USD","LU1974910355.USD","LU2471134952.CNY","LU0820561818.USD","LU1917777945.USD","BK4516","LU0820562030.AUD","LU1720051017.SGD","LU2417539215.USD","IBB","LU0353189680.USD","FTXH","IE0004445239.USD","LU0109391861.USD","PJP","GB00BDT5M118.USD","IE0002141913.USD","LU2168564149.EUR","LU1035775433.USD","LABU","LU1868836591.USD","LU0079474960.USD","LU1093756325.SGD","MRNX","SG9999015952.SGD","LU1629891620.HKD","LU0689472784.USD","IE00B4R5TH58.HKD","LU2168563687.JPY","IE00B4JS1V06.HKD","LU0323591593.USD","LU1366192091.USD","SG9999018857.SGD","LU0238689110.USD","LU0823416689.USD","LU1061106388.HKD","LU0354030438.USD","LU2361045086.USD","LU2023251221.USD","LU1988902786.USD","LU0672654240.SGD","LU0882574055.USD","LU0353189763.USD","PPH","SGXZ51526630.SGD","XLV","SGXZ81514606.USD","LU0006306889.USD","LU2750360641.GBP","IE00BKDWB100.SGD","LU2357305700.SGD","LU0432979614.USD","LU0122379950.USD","LU0466842654.USD","LU0256863811.USD","LU2108987350.USD","BK4551","BK4588","LLYZ","LU0640476718.USD","BK4599","LU2461242641.AUD","BK4534","LU1868836757.USD","LU1023059063.AUD","GDOC","IE00BFSS7M15.SGD","IE00BK4W5M84.HKD","IE00BKPKM429.USD","IE0001KFT4U8.USD","LU1691799644.USD","LU2602419157.SGD","BK4585","LU2237443465.HKD","SG9999018865.SGD","LU1983299246.USD","BK4139","IE00BK4W5L77.USD","SG9999014906.USD","LU2112291526.USD","LU0203202063.USD","THNR","LU0234572021.USD","LU2237443549.SGD","LU2361044865.SGD","LU1989771016.USD","LU2361044949.HKD","LU0943347566.SGD","GNOM","LU2213496289.HKD","LU2471134796.USD","SG9999014914.USD","IE0009355771.USD","HRTS","BK4548","IE00BWXC8680.SGD","LU2237443895.HKD","IE00B2B36J28.USD","SG9999015978.USD","IE00BJJMRX11.SGD","CANC","LU2462591350.SGD","LU1623119135.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":8,"totalSize":412,"code":"91000000","status":"200"}]}}